302 related articles for article (PubMed ID: 6883325)
1. Mechanisms of the potentiation of specific antitumor immunity by intratumor injection of Corynebacterium parvum.
Miyata H; Himeno K; Nomoto K
Cancer Res; 1983 Oct; 43(10):4670-5. PubMed ID: 6883325
[TBL] [Abstract][Full Text] [Related]
2. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
Germain RN; Williams RM; Benacerraf B
Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
[TBL] [Abstract][Full Text] [Related]
3. The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity.
Scott MT; Milas L
Cancer Res; 1977 Jun; 37(6):1673-9. PubMed ID: 870181
[TBL] [Abstract][Full Text] [Related]
4. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
Gabizon A; Leibovich SJ; Goldman R
J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
[TBL] [Abstract][Full Text] [Related]
5. Possible mechanisms in the anti-tumour activity of C. parvum.
Cullen RT
Dev Biol Stand; 1977 Apr 13-15; 38():265-71. PubMed ID: 305375
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of antitumor action of Corynebacterium parvum: replicating short-lived T cells as the mediators of potentiated tumor-specific immunity.
Tuttle RL; North RJ
J Reticuloendothel Soc; 1976 Sep; 20(3):209-16. PubMed ID: 1086362
[No Abstract] [Full Text] [Related]
7. Alterations of host resistance to Listeria monocytogenes in tumour-bearing mice and the effect of Corynebacterium parvum.
Miyata H; Himeno K; Miake S; Nomoto K
Immunology; 1981 Oct; 44(2):305-10. PubMed ID: 7298070
[TBL] [Abstract][Full Text] [Related]
8. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
[TBL] [Abstract][Full Text] [Related]
9. Effects of Corynebacterium granulosum on weight and histology of lymphoid organs, response to mitogens, skin allografts, and a syngeneic fibrosarcoma in mice.
Milas L; Basic I; Kogelnik HD; Withers HR
Cancer Res; 1975 Sep; 35(9):2365-74. PubMed ID: 807323
[TBL] [Abstract][Full Text] [Related]
10. Changes in cellular components of spleen and lymph node cells and the effector cells responsible for Meth A tumor eradication induced by zinostatin stimalamer.
Masuda E; Maeda H
Cancer Res; 1996 Apr; 56(8):1868-73. PubMed ID: 8620506
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
Gomi K; Morimoto M; Nomoto K
Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
[TBL] [Abstract][Full Text] [Related]
12. In vivo transfer of antitumor activity by peritoneal exudate cells from mice treated with C. parvum.
Peters LJ; McBride WH; Mason KA; Hunter N; BasÃc I; Milas L
Dev Biol Stand; 1977 Apr 13-15; 38():297-300. PubMed ID: 608514
[TBL] [Abstract][Full Text] [Related]
13. In vitro antitumor effect of lymphoid cells from Corynebacterium parvum-treated mice: effect of route of C. parvum administration.
Ghaffar A; Cullen RT
J Natl Cancer Inst; 1977 Mar; 58(3):717-20. PubMed ID: 300113
[TBL] [Abstract][Full Text] [Related]
14. Effector mechanism in concomitant immunity potentiated by intratumoral injection of Nocardia rubra cell wall skeleton.
Ogura T; Hara H; Yokota S; Hosoe S; Kawase I; Kishimoto S; Yamamura Y
Cancer Res; 1985 Dec; 45(12 Pt 1):6371-5. PubMed ID: 4063987
[TBL] [Abstract][Full Text] [Related]
15. Accessory cell function in tumor-bearing mice and effects of Corynebacterium parvum.
Okuda S; Taniguchi K; Kubo C; Nomoto K
J Natl Cancer Inst; 1982 Dec; 69(6):1293-7. PubMed ID: 6292563
[TBL] [Abstract][Full Text] [Related]
16. [Antitumor effect of Corynebacterium parvum on C3H mouse bearing MH-134 tumor].
Nakamura K; Miwa H; Hashimoto O; Inoue T; Orita K
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1046-51. PubMed ID: 7184438
[TBL] [Abstract][Full Text] [Related]
17. Role of T-cell subsets in the destruction of established metastases of 13762A rat mammary adenocarcinoma.
Howell LE; Kreider JW; Bartlett GL
J Natl Cancer Inst; 1986 Jul; 77(1):187-93. PubMed ID: 3487670
[TBL] [Abstract][Full Text] [Related]
18. Effect of Corynebacterium parvum on cytotoxicity of regional and nonregional lymph node cells from animals with tumors present or removed.
Fisher B; Wolmark N; Coyle J
J Natl Cancer Inst; 1974 Dec; 53(6):1793-801. PubMed ID: 4471644
[No Abstract] [Full Text] [Related]
19. Immunoregulation of antitumor response; differential secretion of arachidonic acid metabolites by macrophages during stimulation in vitro with BCG and Corynebacterium parvum.
Tomecki J; Sukiennik J; Kordowiak A
Arch Immunol Ther Exp (Warsz); 1993; 41(1):45-50. PubMed ID: 8239907
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and in vivo homing of long-term T-cell lines and clones derived from tumor-draining lymph nodes.
Matsumura T; Sussman JJ; Krinock RA; Chang AE; Shu S
Cancer Res; 1994 May; 54(10):2744-50. PubMed ID: 8168105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
